GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Change In Other Working Capital

Big Pharma Split (FRA:XN4) Change In Other Working Capital : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Big Pharma Split Change In Other Working Capital?

Big Pharma Split's Change In Other Working Capital for the quarter that ended in Jun. 2024 was €0.00 Mil. It means Big Pharma Split's Other Working Capital stayed the same from Dec. 2023 to Jun. 2024 .

Big Pharma Split's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Big Pharma Split's Other Working Capital stayed the same from Dec. 2022 to Dec. 2023 .

Big Pharma Split Change In Other Working Capital Historical Data

The historical data trend for Big Pharma Split's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Change In Other Working Capital Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Big Pharma Split Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Change In Other Working Capital
Comparable Companies
TSXV:AIVC TSXV:MIVO NEOE:JPEG TSXV:CLCO XCNQ:SOL TSXV:CSOC.A TSX:XTD XCNQ:TLP.UN TSXV:ELC XCNQ:LFG BLK KKR BX TSX:BAM OSTO:INVE A TSX:BN APO LSE:III AMP ARES
Traded in Other Exchanges
PRM.PR.A.PFD:Canada PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split Headlines

No Headlines